The Missouri Pharmacy Association is examining the latest deal President Trump has reached with the pharmaceutical industry. Nine drug makers — Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead Sciences, GSK, Merck, Novartis, and Sanofi — have agreed to lower prices to those paid by patients in other developed countries. Missouri Pharmacy CEO Ron Fitzwater […]
